Criteria to qualify for study: Drug used in study:
  • Completed EOS visit in Study NEOD001-201/ANC >1.0/Plt >75/Hgb>9.

AMY 04 NEOD001-OLE251

A phase 2b Open-label Extension Study to evaluate the Long-Term safety and efficacy of NEOD001 in subjects with light-chain (AL) Amyloidosis who were previously enrolled in Study neod001-201 (PRONTO)